e-learning
resources
Virtual 2020
Monday, 07.09.2020
Screening and imaging in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer
C. Simsek (Ankara, Turkey), B. Uzmezoglu (Ankara, Turkey), O. Algin (Ankara, Turkey), G. Sari (Ankara, Turkey)
Source:
Virtual Congress 2020 – Screening and imaging in lung cancer
Session:
Screening and imaging in lung cancer
Session type:
Oral Presentation
Number:
4170
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Simsek (Ankara, Turkey), B. Uzmezoglu (Ankara, Turkey), O. Algin (Ankara, Turkey), G. Sari (Ankara, Turkey). A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer. 4170
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001
The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Surgical biopsy results of our patients with diffuse parenchymal lung diseases
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Neurofibromatosis-associated lung disease: a case series and literature review
Source: Eur Respir J 2007; 29: 210-214
Year: 2007
A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Analyses of predictive findings indicative of progressive interstitial lung diseases
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept